Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

ClinicalTrials.gov ID: NCT01746095

Public ClinicalTrials.gov record NCT01746095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 11:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double Blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether AeroVanc treatment is safe and effective in reducing the number of MRSA colony forming units in the lungs of cystic fibrosis patients.

Study identification

NCT ID
NCT01746095
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Savara Inc.
Industry
Enrollment
87 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2013 (Type not available)
Primary completion
Nov 2014 (Actual)
Completion
Nov 2014 (Actual)
Last update posted
Jan 13, 2020

2013 – 2014

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
35
Facility City State ZIP Site status
Pulmonary Associates of Mobile Mobile Alabama 36608 —
University of Arkansas for Medical Science Little Rock Arkansas 72205 —
Children's Hospital Los Angeles, Division of Pediatric Pulmonology Los Angeles California 90027 —
National Jewish Health Denver Colorado 80206 —
Joe DiMaggio Children's Hospital Hollywood Florida 33021 —
University of Miami - Miller School of Medicine Miami Florida 33136 —
Central Florida Pulmonary Group Orlando Florida 32803 —
Nemours Children's Clinic and Hospital Orlando Florida 32806 —
New Lung Associates, PA; Lung Transplant, Adult Cystic Fibrosis, and the Center for Advanced Lung Diseases, Tampa General Hospital Tampa Florida 33606 —
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 —
The Cystic Fibrosis Center of Chicago Glenview Illinois 60025 —
University of Kansas Medical Center Kansas City Kansas 66160 —
University of Kentucky Cystic Fibrosis Clinic Lexington Kentucky 40536 —
University of Louisville Louisville Kentucky 40202 —
Massachusetts General Hospital Pediatric Cystic Fibrosis Center Boston Massachusetts 02114 —
Boston Children's Hospital Cystic Fibrosis Center Boston Massachusetts 02115 —
Wayne State University, Harper Hospital, Children's Hospital of Michigan Detroit Michigan 48201 —
Washington University School of Medicine St Louis Missouri 63110 —
Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
Hofstra North Shore - Long Island Jewish School of Medicine New Hyde Park New York 11040 —
Columbia University Medical Center New York New York 10032 —
University of North Carolina Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27710 —
Rainbow Babies and Children's Hospital / University Hospitals Case Medical Center Cleveland Ohio 44106 —
Nationwide Children's Hospital Columbus Ohio 43205 —
The Children's Medical Center of Dayton Dayton Ohio 45404 —
Santiago Reyes, MD Oklahoma City Oklahoma 73112 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
Medical University of South Carolina Charleston South Carolina 29425 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Dell Children's Medical Center of Central Texas Austin Texas 78723 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Baylor College of Medicine and Texas Children's Hospital Houston Texas 77030 —
University of Texas Health Science Center at Tyler Tyler Texas 75708 —
University of Utah, Intermountain Cystic Fibrosis Center Salt Lake City Utah 84132 —
University of Washington Medical Center Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01746095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2020 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01746095 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →